Skip to main content

Advertisement

SpringerLink
Log in

Clinicohistoradiological and surgical outcome in diffuse midline glioma

  • Original Article
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Purpose

Diffuse Midline Glioma (DMG) with H3K27M mutation is a rare and aggressive midline high grade glioma with a predominant astrocytic differentiation and K27M mutation in either H3F3A or HIST1H3B/C. This tumor is more common in children than in adults. The current study was aimed to determine clinicohistoradiological and surgical outcome of patients who have undergone surgery for DMG and study disease severity of patients with DMG.

Methods

This is an observational study in which 29 DMG patients were evaluated for clinicohistoradiological and surgical outcomes by assessing the pre and postoperative neurological status.

Result

Survival duration was significantly high in patients with age > 18 years (p = 0.02). Patients who had undergone Radiation Therapy showed higher survival rate (p = 0.05) and the cases with low levels of Ki 67 index had improved post operative outcome (p = 0.002).

Conclusion

DMG with H3K27M mutation in newly classified Central Nervous System tumor are WHO grade IV Tumors, comprising H3K27M mutation as molecular marker for diagnosis and related with a poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Katherine E. Warren (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol

  2. Taylor KR (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46:457–461

  3. Wu G (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251

  4. Wu G (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444–450

  5. Schwartzentruber J (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Natures 482:226–231

  6. Da KQ (2012) K27M mutation in histone H3.3 defines clinically andbiologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124

  7. Lu VM.(2018) Impact of theH3K27M mutation on survival in pediatric high-grade glioma: asystematic review and meta-analysis. J Neurosurgery Pedia. 1:1–9

  8. López G (2017) Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol

  9. Piunti A (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23:493–500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Grasso et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:827

    Article  CAS  PubMed  Google Scholar 

  11. Morales La Madrid AH (2015) Future clinical trialsin DIPG: bringing epigenetics to the clinic. Front Oncol 2015

  12. Silveira AB (2019) H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo [published correction appears in Acta Neuropathol. Acta Neuropathol 137(4):637–655

  13. Bender S (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24:660–672

    Article  CAS  PubMed  Google Scholar 

  14. Capper D (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. National Cancer Institute. Available from: https://www.cancer.gov/rare-brain-spine-tumor/tumors/diffuse-midline-gliomas

  16. Gallitto MLS (2019) Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review. Adv Rad Oncol p. 520–531

  17. Abe H, Natsumeda M, Kanemaru Y, Watanabe J, Tsukamoto Y, Okada M, Yoshimura J, Oishi M, Fujii Y (2018) MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas. Neurol Med Chir (Tokyo) 58(7):290–295. https://doi.org/10.2176/nmc.ra.2018-0044. Epub 2018 May 31

    Article  PubMed  Google Scholar 

  18. Gupta N. Brain center tumouruscf. Available from: https://braintumorcenter.ucsf.edu/condition/diffuse-midline-glioma,

  19. Dufour C, Perbet R, Leblond P, Vasseur R, Stechly L (2019) Identification of prognostic markers in diffuse midline gliomas H3K27M mutant. Brain Pathol

  20. Peter W. Lewis, Manuel M. Müller, Matthew S. Koletsky, Francisco Cordero, Shu Lin, Laura A. Banaszynski, Benjamin A. Garcia, Tom W. Muir, Oren J. Becher, And C. David Allis(2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340:857–861,

  21. Toshiyuki EM (2020) Midline Glioma in Adults:Clinicopathological,Genetic, and Epigenetic Analysis. Neurol Med Chir (Tokyo) 60:136–146

  22. Ernst T (2012) Inactivation of polycomb repressive complex components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms. Europe PMC 119:1208–1213

  23. Nikoloski G. (2010)Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet. .42:665–66

  24. Ntziachristos P. (.2012)Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med .18:298–301

  25. Stransky N. (2011)The mutational landscape of head and neck squamous cell carcinoma. Science. 333:1157–1160

  26. Zhang J. (2012)The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature.481:157–163

  27. Haihui Jiang KY (2020) Diffuse midline glioma with H3 K27M mutation: acomparison integrating the clinical, radiological, and molecular features between adult andpediatric patients. Neuro Oncol

  28. Lim JX (2020) H3K27M-mutant diffuse midline glioma presenting as synchronouslesions involving pineal and suprasellar region: A case reportlesions involving pineal and suprasellar region: A case reportlesions involving pineal and suprasellar region: A case report. Singapore: National Neuroscience Institute, Department of Neurosurgery

  29. Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N (2015) Diffuse Midline Gliomas with Histone H3-K27M Mutation:A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Brain Pathol

  30. Korones DN (2017) Treatment of newly diagnosed diffuse brain stem gliomas in children: in search ofthe holy grail. Expert Rev Anticancer Ther

  31. Enomoto et al (2020) Neurol Med Chir (Tokyo) 60(3):136–146

  32. Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, Holdhoff M (2019) Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographicallydetermined midline gliomas. J Neurooncol 143:87–93. https://doi.org/10.1007/s11060-019-03134-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Cohen KJ, Jabado N, Grill J (2017) (Diffuse intrinsic pontine gliomas—current management and newbiologic insights. Is there a glimmer of hope). Neuro Oncol 19(8):1025–1034

  34. Elena V Daoud, Veena Rajaram, Chunyu Cai, Robert J Oberle, Gregory R Martin, Jack M Raisanen, Charles L White, III, Chan Foong, Bruce E Mickey, Edward Pan, Kimmo J Hatanpaa,(2018) Adult Brainstem Gliomas WithH3K27M Mutation: Radiology, Pathology, and Prognosis. J Neuropathol Exp Neurol 77(4):302–31

Download references

Acknowledgements

We are thankful for the support and assistance received from the faculty, residents, technical and non-technical staff members of Department of Neurosurgery, Nizam’s Institute of Medical Sciences, Hyderabad.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India, 229 405

    Arvind Kumar Suman

  2. Department of Neurosurgery, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India, 500 082

    Suchanda Bhattacharjee

  3. Department of Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India, 500 082

    Megha S. Uppin

  4. Department of Neurology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India, 500 082

    Syed Tazeem Fathima

Authors
  1. Arvind Kumar Suman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suchanda Bhattacharjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Megha S. Uppin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Syed Tazeem Fathima
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Arvind Kumar: Conception, Organization, Execution, Design, Execution, Writing of the first draft; Suchanda Bhattacharjee: Conception, Organization, Execution, Design, Execution, Review, and critique; Megha S Uppin: Conception, Execution, Review, and critique; Syed Tazeem Fathima: Design, Execution, Review, and critique.

Corresponding author

Correspondence to Arvind Kumar Suman.

Ethics declarations

Ethical compliance statement

All procedures performed in study involving human participants was in accordance with the ethical standards of institutional ethics committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Ethics Committee of Nizam’s Institute of Medical Sciences, Hyderabad, India (EC/NIMS/2466/2019).

Informed consent

Informed consent was obtained from all the study participants. We confirm that we have read the Journal’s position on issues.

Data transparency

The authors declare that they comply with field standards.

Competing interest

The authors declare that there is no competing of interest relevant to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar Suman, A., Bhattacharjee, S., Uppin, M.S. et al. Clinicohistoradiological and surgical outcome in diffuse midline glioma. Childs Nerv Syst 40, 65–71 (2024). https://doi.org/10.1007/s00381-023-06095-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-023-06095-9

Keywords

Search

Navigation